A medtech product’s market niche and patentability are critical factors in winning seed funding, according to a panel of startup experts at an Innovators’ Forum at Boston Children’s Hospital this week.
GeNO Healthcare
Drug delivery tech maker GeNO files for IPO of up to $50M
Waltham, Mass.-based GeNO LLC is hoping to raise as much as $50 million through an initial public offering, with funds slated to further development and commercialization of the company’s GeNOsyl drug delivery technology.